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Abstract
Background: Hypertension affects > 18.8% of adults in China. Indeed, hypertension is the most
prevalent risk factor for cardiovascular morbidity and mortality worldwide. Genetic variation is
thought to contribute to the etiology of hypertension. NEDD4L  is a candidate gene for
hypertension, both functionally and genetically. The purpose of the current study was to investigate
the relationship between the variation in NEDD4L and essential hypertension in Kazakh, which is a
relatively isolated population with a pure genetic background and is an ideal population to study
genetic mechanisms of hypertension.
Methods: We screened the promoter and exons of NEDD4L in 94 Kazakh hypertensive individuals
to identify representative variations. Then, by genotyping the representative variations in the
Kazakh general population, a case-control study was conducted.
Results:  By systemically screening variations of NEDD4L, we did not identify any functional
mutations in NEDD4L. A new common variation (296921-296923delTTG), which is not found in
the NCBI database, was identified. Three representative variations (296921-296923delTTG,
rs2288774, and rs2288775) were successfully genotyped in the Kazakh general population. The
distribution of the dominant model (AA vs. AG+GG) of rs2288775, the additive model, and the
recessive model (II+ID vs. DD) of 296921-296923delTTG differed significantly between the cases
and controls in females (P = 0.040, P = 0.024, and P = 0.007, respectively). After adjusting for
confounding factors, logistic regression analysis showed that rs2288775 (in the dominant model)
and 296921-296923delTTG (in the recessive model) were significantly associated with
hypertension (rs2288775: OR = 1.479, 95% CI = 1.011-2.064, p  = 0.044; and 296921-
296923delTTG: OR = 1.908, 95% CI = 1.020-3.568, p = 0.043) in females. The frequency of the D-
C-G haplotype was significantly higher for cases than for controls in females (P = 0.020). There was
a significant interaction between the NEDD4L genotype and gender (P for interaction: 0.045 for
rs2288775 and 0.064 for 296921-296923delTTG), but there was no significant interaction between
the NEDD4L genotype and smoking (P for interaction: 0.616 for rs2288775 and 0.447 for 296921-
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296923delTTG). For females and total participants, the urinary Na excretion rate was significantly
lower in the DD than the I/I+I/D individuals (P = 0.032 and P = 0.027 respectively).
Conclusion: The genetic variations of NEDD4L may be associated with essential hypertension in
females in the Kazakh general population.
Background
Hypertension affects > 18.8% of the adult population in
China. Indeed, hypertension is the most prevalent risk fac-
tor for cardiovascular morbidity and mortality worldwide
[1]. However, the etiology of > 90% of patients with
hypertension is unknown. Studies have revealed that
essential hypertension is a complex phenotype in which
genetic factors explain 30%-60% of all variations in the
population [2]. Thus, it is important for the prevention
and treatment of essential hypertension to identify the
susceptible genes in different populations.
A region on chromosome 18q21-22 has been identified in
a number of genome-wide scans on hypertension, there-
fore making the locus a suitable candidate for harboring
gene/genes involved in blood pressure (BP) regulation
[3,4]. The 18q21-22 locus harbors an important BP-regu-
lating gene (the neural precursor cell expressed develop-
mentally down-regulated 4-like [NEDD4L] gene).
NEDD4L regulates BP through its ubiquitinating effects
on the epithelial sodium channel (ENaC), a critical com-
ponent of the pathway maintaining salt and water balance
[5] at the luminal cell membrane in the renal collecting
ducts [6-8], resulting in reduction of the number of ENaC
present on the plasma membrane. Peijun et al. demon-
strated that NEDD4L knockout mice have high BP and an
impaired ability to down-regulate ENaC activity [9]. Thus,
NEDD4L is a candidate gene for essential hypertension.
Recently, a common polymorphism located at intron 2
(rs4149601) of the NEDD4L gene was shown to be asso-
ciated with hypertension both in African Americans and
Caucasians, and a "flip-flop" association with hyperten-
sion was found in two Caucasian samples [10] for a com-
mon polymorphism located at intron 12 (rs3865418).
However, there are no reports regarding the relationship
between genetic variations in the human NEDD4L gene
and essential hypertension in Kazakh, which is an ideal
population to study genetic mechanisms of hypertension.
Kazakh, a nomad population which dwells north of Xin-
jiang in northwest China and in which 99% are herds-
man, is characterized by a higher prevalence of
hypertension and higher BP levels compared to other eth-
nic populations residing in the same area [11]. Moreover,
the hypertension in this population is salt-sensitive and
BP decreases significantly after limiting salt intake [11]. A
previous study has confirmed that compared with other
populations, including Mongolian, Hui, Tibetan, Uygur,
Miao, Yi, Zhuang, Buyi, Man, Yao, and Tujia, the Kazakh
population has a higher dairy intake, with an average
daily consumption > 21 g [12]. Furthermore, very few
Kazakh marry people of other ethnicities because the
unique customs, cultural background, and food habits are
different from other ethnicities. Therefore, Kazakh is a rel-
atively isolated population with a pure genetic back-
ground and is an ideal population to study genetic
mechanisms of complex diseases, such as hypertension.
Essential hypertension, as a complex trait, has been sug-
gested to be caused by common sequence variants that
may have a small-to-moderate phenotypic effect [13-15].
On the other hand, a study has shown that most Mende-
lian disorders are caused by a set of different rare muta-
tions that reside in coding regions, which tend to have
strong phenotypic effects. Recently, several studies have
shown that rare genetic variations in ABCA1, APOA1, and
LCAT collectively contribute to variation in plasma levels
of high-density lipoprotein-cholesterol (HDL-C) in the
general population [16,17]. We therefore hypothesized
that not only common, but also rare genetic variations in
NEDD4L, could contribute to hypertension.
In this study, we sequenced the promoter and all exons of
NEDD4L in 94 Xinjiang Kazakh hypertensive individuals
to identify common single nucleotide polymorphisms
(SNPs) and rare variations, and then genotyped the repre-
sentative variations in the general population to systemi-
cally study whether genetic variations in NEDD4L  are
implicated in essential hypertension in the Xinjiang
Kazakh general population.
Methods
Study population
One thousand Kazakh subjects with no mixed marriages
within the past three generations were randomly recruited
for this study by multistage cluster sampling from the
Fukang area in the Xinjiang Uygur Autonomous Region.
Written consent was obtained from all subjects before any
data collection and measurements. A total of 956 individ-
uals completed the survey during the 1-month period
from January to February 2008, with an overall response
rate of 95.6%. Subjects with secondary hypertension,
excessive drinking, cancer, age < 30 years or > 60 years,
and use of contraceptives were excluded from this study,
leaving a final study population of 883 subjects (375
males and 508 females) for the current set of analyses.BMC Medical Genetics 2009, 10:130 http://www.biomedcentral.com/1471-2350/10/130
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Then, a case-control study was conducted in 383 hyper-
tensive and 500 normotensive subjects. Secondary hyper-
tension was excluded by history, examination, and
laboratory evaluation. This study was approved by the
Ethics Committee of the People's Hospital of Xinjiang.
Diagnostic criteria and measurements
In light of a common protocol recommended by the
American Heart Association Anthropometric measure-
ments, the BP measurement was performed by trained
and certified observers 3 times per subject with at least 10
min of rest in a sitting position and the mean value was
considered the final BP value. In addition to performing
routine blood testing that included lipid profiles, plasma
Na, glucose levels, and blood/urine electrolytes, anthro-
pometric measurements were obtained and a question-
naire was completed. The questionnaire included
demographic information, personal history of cardiovas-
cular diseases (angina pectoris, myocardial infarction, or
stroke), and detailed personal and family histories of
hypertension, overweight/obesity, diabetes mellitus, drug
treatment, education, alcohol consumption, and cigarette
smoking. The urinary Na excretion rate (UNa rate) was
calculated as UNa*UV/24 h, where UNa* was the urinary
concentration of Na, and UV was the urinary volume in
24 h. Body height and weight were used to calculate the
body mass index (BMI; weight in kilograms divided by the
height in meters squared). The diagnostic criteria for
hypertension were defined as follows: a systolic blood
pressure (SBP) ≥ 140 mmHg and/or a diastolic blood
pressure (DBP) ≥ 90 mmHg or anti-hypertension treat-
ment according to the WHO definition of hypertension in
1999. Non-hypertensive participants met the following
criteria: no history of any anti-hypertensive medications
and a SBP < 140 mmHg and a DBP < 90 mmHg.
Overweight and obesity were defined according to the cri-
teria of WHO: normal weight, BMI < 25 kg/m2; over-
weight, 25 kg/m2 ≤ BMI ≤ 30 kg/m2; and obesity, BMI > 30
kg/m2.
Dyslipidemia was diagnosed according to the Guidelines
for the Prevention and Control of Dyslipidemia in Chi-
nese Adults as follows: total cholesterol (TC), ≥ 5.7 mmol/
L; HDL-C, < 1.04 mmol/L; or low density lipoprotein-cho-
lesterol (LDL-C), ≥ 3.37 mmol/L; or triglycerides (TG), ≥
1.7 mmol/L.
Hyperglycemia was defined as a fasting blood glucose
(FBG) ≥ 6.1 mmol/L or a 2-hour postprandial glucose (2
HPG) ≥ 7.8 mmol/L.
Screening for genetic variations in NEDD4L in 
hypertensivepatients
We sequenced all exons and the promoter region of
NEDD4L. Blood samples were obtained from 94 (47
males and 47 females) hypertensive patients, which were
randomly chosen from the hypertensive group of the
study population, and genomic DNA was isolated from
peripheral blood leukocytes using a PAXgene Blood DNA
kit (PreAnalytiX). All exons with their flanking sequences
and approximately 500 bp of the upstream region of the
promoter were directly sequenced by an ABI 3130Xl
genetic analyzer (Applied Biosystems, Foster City, CA,
USA) using 35 sets of primers, as described previously
[18]. The obtained sequences were examined for the pres-
ence of variations using Sequencher 4.7 software (Gene
Codes Corporation, Ann Arbor, MI, USA), followed by
visual inspection. The A of the ATG of the initiator Met
codon is denoted nucleotide +1. The nucleotide sequence
[NCBI: NM-015277] was used as a reference sequence.
Genotyping of representative SNPs in the general 
population
After considering the function and linkage disequilibrium
relationships among the identified genetic variations, 3
common SNPs with a minor allele frequency of > 10%
were selected as representatives for genotyping (Table 1).
The TaqMan SNP Genotyping Assays were performed for
genotyping using the method of Taq amplification in the
7900 HT Fast Real-Time PCR system (Applied Biosys-
tems). The primers and probes (Applied Biosystems) used
in the TaqMan SNP Genotyping Assays were chosen based
on information available on the Applied Biosystems Inc.
website http://myscience.appliedbiosystems.com. Finally,
all of the three selected representative SNPs were success-
fully genotyped in 883 subjects participating in the study.
Statistical analysis
Data analyses were performed by SPSS for Windows (ver-
sion 16; SPSS Inc., Chicago, IL, USA). Values are expressed
as the means ± SD. The distribution of patient characteris-
tics between the normotensive and hypertensive groups in
the Kazakh general population was analyzed using a Stu-
dent's t-test or a chi-square test. The differences in distri-
butions of genotypes and alleles between the essential
hypertension patients and control individuals were ana-
lyzed using a chi-square test. In addition, logistic regres-
sion analysis was performed to assess the contribution of
the major risk factors (including smoking, drinking, age,
and obesity). Covariate variance analysis was performed
to compare the UNa rate and plasma Na level between the
different genotypes after adjusting for age, smoking, and
drinking. Two-way ANOVA (covariates: age and BMI) was
used to assess interaction effects of gender and SNPs on
BP traits, as well as interactions of smoking and SNPs. The
frequency distribution of the haplotypes was calculated by
chi-squared analysis. A case-control-based haplotype
study, linkage disequilibrium, and the Hardy-Weinberg
equilibrium were analyzed using SNPAlyze, version 7.0
Pro (DYNACOM Co. Ltd., Mobara, Japan). Statistical sig-
nificance was established at P values < 0.05.BMC Medical Genetics 2009, 10:130 http://www.biomedcentral.com/1471-2350/10/130
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Results
Eleven genetic variations in NEDD4L were identified by
sequencing 94 hypertensive individuals, among which
there were 3 common SNPs with a minor allele frequency
> 10% (271420T>C, 271454A>G, and 296921-
296923delTTG). 296921-296923delTTG is a new genetic
common variation in NEDD4L which is not found in the
NCBI SNP-database. No missense mutations in NEDD4L
were identified, but we identified the following two syn-
onymous mutations: R423 (297071G>A in exon14) with
a minor allele frequency of 0.91%; and A944 (351555C>T
in exon 30) with a minor allele frequency of 0.56% (Table
1). None of the variations were in tight linkage disequilib-
rium with an r2 < 0.5 (Table 1).
Next, we looked for an association in the Kazakh general
population between selected representative SNPs of
NEDD4L and essential hypertension. Table 2 presents the
clinical characteristics of the study participants. For males,
females, and total participants, the following values were
significantly higher for the essential hypertension patients
than the control individuals: age, BMI, SBP, DBP, TC, TG,
and FBG. There was no significant difference in HDL-C,
UNa rate, and plasma Na level between the essential
hypertension patients and the control individuals. The
incidence of obesity, dyslipidemia, and hyperglycemia
was significantly higher in the case group. There was no
significant difference in the prevalence of smoking and
drinking between the essential hypertension patients and
control individuals.
Table 3 presents the distribution of the genotypes and
alleles of the 3 common SNPs. The genotype distribution
of each SNP was in Hardy-Weinberg equilibrium (data
not shown). Power analyses revealed that our study had a
power of 0.95 (for D-carrying genotype of 296921-
296923delTTG) and 0.79 (for G-carrying genotype of
rs2288775) to detect the difference across cases and con-
trols in this study (α = 0.05). For total and male partici-
pants, the genotype distribution of the three SNPs did not
differ significantly between the essential hypertension
patients and the control individuals. For the females, the
distribution of genotypes of rs2288775 differed signifi-
cantly between the essential hypertension patients and
the control individuals in the dominant model (AA vs.
AG+GG,  P  = 0.040). The genotype distributions of
296921-296923delTTG were significantly different
between the essential hypertension patients and the con-
trol individuals in the additive (P = 0.024) and recessive
models (II+ID vs. DD, P = 0.007). The allelic frequencies
of rs2288775 and 296921-296923delTTG were signifi-
cantly different between the case and control groups (P =
0.038 and P = 0.028, respectively). Furthermore, there was
a significant interaction between the NEDD4L genotype
Table 1: Sequence variations in the promoter region and exons in Nedd4L identified in Kazakh hypertensive patients
SNP name Region Amino acid 
substitution
Allele 1 freq Allele 2 freq Flanking sequence Typing db SNP ID
-608C>G promoter 0.9877 0.0123 cgccgcgccg[c/
g]gctggaggcc
-548G>A promoter 0.9813 0.0187 cgcagcccgc[g/
a]gcccgctcgc
271420T>C intron6 0.5989 0.4011 ttgtagtcag[t/
c]gtattttcag
Taqman rs2288774
271454A>G intron6 0.7692 0.2308 caccacggtg[a/
g]agaaggctga
Taqman rs2288775
296921-296923delTTG intron13 0.7381 0.2619 ttgcgttg[ttg/---
]tttgggtt
Taqman
297071G>A exon14 R423R 0.9909 0.0091 AGATCCGCCG[G/
A]CCTCGTAGCC
312644T>G intron18 0.9731 0.0269 tcttgtgtat[t/
g]actgataacg
312671C>T intron18 0.9624 0.0376 caagggacaa[c/
t]ggtgattgag
325828A>G intron22 0.9765 0.0235 atcaccgggc[a/
g]ctcgtgtctt
340782G>C intron24 0.9892 0.0108 actccctgtt[g/
c]cggagaaagc
351555C>T exon30 A944A 0.9944 0.0056 TTCTCATGGC[C/
T]GTGGAAAATG
Sequence variations were screened in 94 hypertensive patients. Taqman, The single nucleotide polymorphism (SNP) was successfully genotyped by 
the Taqman method. The A of the ATG of the initiator Met codon is denoted nucleotide +1, as recommended by the Nomenclature Working 
Group (Hum Mut 1998; 11:1--3). The nucleotide sequence [NCBI: NM-015277] wasused as a reference sequence.BMC Medical Genetics 2009, 10:130 http://www.biomedcentral.com/1471-2350/10/130
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and gender (P for interaction: 0.045 for rs2288775 and
0.064 for 296921-296923delTTG), but no significant
interaction between the NEDD4L genotype and smoking
existed (P for interaction: 0.616 for rs2288775 and 0.447
for 296921-296923delTTG).
After adjusting for confounding factors (age, smoking,
drinking, and obesity), multivariate logistic regression
analysis also showed that rs2288775 (in the dominant
model) and 296921-296923delTTG (in the recessive
model) were significantly associated with hypertension
(rs2288775: OR = 1.479, 95% CI = 1.011-2.064, p  =
0.044; 296921-296923delTTG: OR = 1.908, 95% CI =
1.020-3.568, p = 0.043; Table 4).
In the haplotype-based case-control analysis, haplotypes
were established in three representative common SNPs
(Table 5). For the total population and males, the distri-
bution of the haplotypes was not significantly different
between the essential hypertension patients and the con-
trol individuals. For females, the frequency of D-C-G hap-
lotype (established by 296921-296923delTTG,
rs2288774, and rs2288775) were significantly higher for
the essential hypertension patients than for the control
individuals (P = 0.020).
Table 6 presents the comparison of the UNa rate and
plasma Na between the different genotypes by covariate
variance analysis, adjusting for age, smoking, and drink-
ing. For females and the total participants, the UNa rate
was significantly lower for the DD than the I/I+I/D indi-
viduals (P = 0.032 and P = 0.027, respectively). There was
no significant difference in the plasma Na level between
the genotypes.
Table 2: Basic characteristics of subjects in hypertensives and normotensives
Total Male Female
Control
(n = 500)
Case
(n = 383)
P Control
(n = 204)
Case
(n = 171)
P Control
(n = 296)
Case
(n = 212)
P
Age
(year)
42.04 ± 7.35 46.23 ± 7.63 < 0.001* 42.24 ± 7.48 46.11 ± 7.97 < 0.001* 41.90 ± 7.28 46.34 ± 7.37 < 0.001*
BMI
(kg/m2)
25.27 ± 3.55 28.14 ± 4.50 < 0.001* 25.39 ± 3.23 28.52 ± 4.22 < 0.001* 25.18 ± 3.76 27.83 ± 4.70 < 0.001*
SBP
(mmHg)
117.78 ± 
11.11
150.60 ± 
25.90
< 0.001* 119.43 ± 
10.58
149.28 ± 
25.67
< 0.001* 116.65 ± 
11.34
151.67 ± 
26.11
< 0.001*
DBP
(mmHg)
78.28 ± 7.53 96.88 ± 10.92 < 0.001* 80.29 ± 6.24 97.03 ± 10.45 < 0.001* 76.88 ± 8.04 96.76 ± 11.32 < 0.001*
TC
(mmol/L)
4.88 ± 1.00 5.14 ± 1.05 < 0.001* 5.09 ± 1.07 5.26 ± 1.03 0.111 4.84 ± 0.93 5.05 ± 1.06 0.001*
HDL
(mmol/L)
1.47 ± 0.38 1.44 ± 0.39 0.244 1.31 ± 0.34 1.27 ± 0.31 0.244 1.58 ± 0.37 1.58 ± 0.40 0.927
TG
(mmol/L)
1.00 ± 0.60 1.23 ± 0.74 < 0.001* 1.23 ± 0.75 1.53 ± 0.91 0.001* 0.85 ± 0.43 0.99 ± 0.46 0.001*
FBG
(mmol/L)
4.83 ± 0.65 5.08 ± 1.35 0.001* 4.95 ± 0.63 5.21 ± 1.59 0.050 4.75 ± 0.65 4.98 ± 1.12 0.008*
UNa rate 
(uM/min)
163.78 ± 
85.55
171.14 ± 
87.57
0.260 182.64 ± 
93.98
190.79 ± 
88.33
0.439 150.31 ± 
76.39
155.27 ± 
83.90
0.536
Pl Na (mmol/L) 144.57 ± 8.98 144.74 ± 8.75 0.785 145.91 ± 9.32 145.09 ± 7.34 0.353 143.67 ± 8.66 144.45 ± 9.74 0.338
Life style
Smoking
(%)
22.8 24.3 0.606 55.4 52.6 0.593 0.3 1.4 0.176
Drinking
(%)
21.6 21.1 0.871 52.0 44.4 0.147 0.7 2.4 0.109
Present illness
Overweight 
(%)
49.9 74.3 0.000* 53.1 79.8 0.000* 47.7 69.8 0.000*
Dyslipidemia 
(%)
38.9 53.4 0.000* 60.0 68.8 0.078 24.7 41.0 0.000*
Hyperglycemia 
(%)
16.7 25.2 0.002* 15.5 23.5 0.057 17.4 26.6 0.014*
BMI; body mass index, SBP; systolic blood pressure, DBP; diastolic blood pressure, TC; total cholesterol, HDL-c; high-density lipoprotein 
cholesterol. TG; triglyceride, FBG; fasting blood glucose, Una rate; urinary Na excretion rate, PlNa; plasma Na. Values are mean ± SD or 
percentage. P < 0.05 was considered significant. The differences between case and control group were performed by t-test or X2 test.
* P < 0.05BMC Medical Genetics 2009, 10:130 http://www.biomedcentral.com/1471-2350/10/130
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Table 3: Genotype and allele distributions in patients with essential hypertension and in control individuals
Total Male Female
SNPs Genotype Case 
(n = 383)
Control 
(n = 500)
P Case 
(n = 171)
Control 
(n = 204)
P Case 
(n = 212)
Control 
(n = 296)
P
rs2288774 
n(%)
Additive 
model
T/T 123
(32.5)
177 (35.8) 0.365 60 (35.7) 71 (35.1) 0.661 63 (30.0) 106 (36.2) 0.296
C/T 173
(45.8)
228 (46.1) 76 (45.2) 99 (49.0) 97 (46.2) 129 (44.0)
C/C 82 (21.7) 90 (18.1) 32 (19.1) 32 (15.9) 50 (23.8) 58 (19.8)
Dominant 
model
T/T 123
(32.5)
177 (35.8) 0.984 60 (35.7) 71 (35.1) 0.909 63 (30.0) 106 (36.2) 0.148
T/C+C/C 255
(67.5)
318 (64.2) 108 (64.3) 131 (64.9) 147 (70.0) 187 (63.8)
Recessive 
model
T/T+C/T 296
(78.3)
405 (81.9) 0.192 136 (80.9) 170 (84.1) 0.417 160 (76.2) 235 (80.2) 0.279
C/C 82 (21.7) 90 (18.1) 32 (19.1) 32 (15.9) 50 (23.8) 58 (19.8)
Allele T 419
(55.4)
582 (58.8) 0.159 196 (58.3) 241 (59.7) 0.716 223 (53.1) 341 (58.2) 0.108
C3 3 7
(44.6)
409 (41.2) 140 (41.7) 163 (40.3) 197 (46.9) 245 (41.8)
rs2288775 
n(%)
Additive 
model
A/A 210
(55.0)
302 (60.9) 0.189 100 (58.8) 122 (60.7) 0.901 110 (51.9) 180 (61.0) 0.114
A/G 146
(38.2)
168 (33.9) 61 (35.9) 70 (34.8) 85 (40.1) 98 (33.2)
G/G 26 (6.8) 26 (5.2) 9 (5.3) 9 (4.5) 17 (8.0) 17 (5.8)
Dominant 
model
A/A 210
(55.0)
302 (60.9) 0.078 100 (58.8) 122 (60.7) 0.714 110 (51.9) 180 (61.0) 0.040*
A/G+G/G 172
(45.0)
194 (39.1) 70 (41.2) 79 (39.3) 102 (48.1) 115 (39.0)
Recessive 
model
A/A+AG 356
(93.2)
470 (94.8) 0.948 161 (94.7) 192 (95.5) 0.715 195 (92.0) 278 (94.2) 0.316
G/G 26 (6.8) 26 (5.2) 9 (5.3) 9 (4.5) 17 (8.0) 17 (5.8)
Allele A 566
(74.1)
772 (77.8) 0.065 261 (76.8) 314 (78.1) 0.662 305 (71.9) 458 (77.6) 0.038*
G1 9 8
(25.9)
220 (22.2) 79 (23.2) 88 (21.9) 119 (28.1) 132 (22.4)
296921-
296923 
delTTG n(%)
Additive 
model
I/I 186
(48.8)
258 (52.3) 0.217 91 (53.5) 111 (54.7) 0.674 95 (45.0) 147 (50.7) 0.024*
I/D 155
(40.7)
199 (40.4) 69 (40.6) 76 (37.4) 86 (40.8) 123 (42.4)
D/D 40 (10.5) 36 (7.3) 10 (5.9) 16 (7.9) 30 (14.2) 20 (6.9)
Dominant 
model
I/I 186
(48.8)
258 (52.3) 0.303 91 (53.5) 111 (54.7) 0.824 95 (45.0) 147 (50.7) 0.210
D/D+I/D 195
(51.2)
235 (47.7) 79 (46.5) 92 (45.3) 116 (55.0) 143 (49.3)
Recessive 
model
I/I+I/D 341
(89.5)
457 (92.7) 0.096 160 (94.1) 187 (92.1) 0.450 181 (85.8) 270 (93.1) 0.007*
D/D 40 (10.5) 36 (7.3) 10 (5.9) 16 (7.9) 30 (14.2) 20 (6.9)
Allele I 527
(69.2)
715 (72.5) 0.125 251 (73.8) 298 (73.4) 0.896 276 (65.4) 417 (71.9) 0.028*
D2 3 5
(30.8)
271 (27.5) 89 (26.2) 108 (26.6) 146 (34.6) 163 (28.1)
* P < 0.05BMC Medical Genetics 2009, 10:130 http://www.biomedcentral.com/1471-2350/10/130
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The associations between the SNPs and overweight, dysli-
pidemia, hyperglycemia, and central obesity were also
examined, and no significant associations were found
(Additional file 1).
Discussion
In this study by systemically screening variations of
NEDD4L we did not identify any functional mutations in
NEDD4L. By studying the associations of 3 representative
common SNPs with hypertension, we first report that two
common SNPs (296921-296923delTTG and rs2288775)
were significantly associated with essential hypertension
in Kazakh females.
It has been reported that NEDD4L plays an important role
in regulating BP [5-8]. Importantly, by studying some
functional SNPs of NEDD4L  chosen from the public
genetic database, several studies have recently demon-
strated that genetic variations of NEDD4L are associated
with hypertension [9,10,19-21]. So NEDD4L is an impor-
tant candidate gene for hypertension, and there is a need
to study its relationship to hypertension comprehensively
from a genetic point of view. In this study, we systemically
studied the association of genetic variations of NEDD4L
with essential hypertension in Xinjiang Kazakh using the
research strategy that we first screened genetic variations
of NEDD4L and then studies the relationship of the repre-
sentative SNPs to hypertension. The research strategy was
selected based on the following: a) the HapMap project
does not provide genetic information for Xinjiang
Kazakh, so we could not use the Tag-SNP specific for
Kazakh in this study; and b) by sequencing the functional
regions with their flanking sequences of NEDD4L in 94
Kazakh hypertensives, we found not only common and
rare SNPs or mutations, both of which are considered to
contribute to the pathogenesis of essential hypertension,
but also novel or race-specific genetic variations.
In this study, we did not find any missense mutations in
NEDD4L. This may be indicative of the relatively high
conservation of NEDD4L and the importance of this mol-
ecule in regulating salt and water balance and BP. A novel
common SNP (296921-296923delTTG) in NEDD4L,
which is not found in the NCBI SNP-database, was signif-
icantly associated with essential hypertension in Kazakh
females. Another polymorphism, rs2288745, located at
the 100 bp downstream exon 6, was also positive in
Kazakh females with essential hypertension. Since signifi-
cant associations of the two common SNPs with essential
hypertension were obtained in the multivariable analysis
with adjustment for confounding risk factors, including
age, obesity, and lifestyle (current smoking and drinking),
the G allele of rs2288745 may be an independent risk fac-
tor for hypertension and the I allele of 296921-
296923delTTG may be an independent protective factor
for hypertension. In the present study, we genotyped three
SNPs that are not in tight linkage disequilibrium, there-
fore we had to perform a correction for multiple testing.
After correction by the Bonferroni method (corrected P =
0.017), no SNPs were significantly associated with hyper-
tension after adjustment for confounding factors. Haplo-
type analysis is considered to be a good method used in
genetic studies for complex diseases while avoiding prob-
lems induced by multiple testing. In this study, one hap-
lotype of NEDD4L  was significantly associated with
essential hypertension. Moreover, power analyses
Table 4: Odds ratios and 95% confidence intervals for two variations of NEDD4L gene associated with essential hypertension in female 
after adjusting smoking, drinking, age and obesity
polymorphism genotype odds ratios 95% confidence interval P
rs2288775 A/A 1
A/G+G/G 1.479 1.011-2.064 0.044*
296921-296923delTTG II+ID 1
D/D 1.908 1.020-3.568 0.043*
* P < 0.05
Table 5: Haplotype analysis in patients with essential hypertension and control participants
Haplotype Total Male Female
296921-
3delTTG
rs2288774 rs2288775 Case
(n = 383)
Control
(n = 500)
P Case
(n = 171)
Control
(n = 204)
P Case
(n = 212)
Control
(n = 296)
P
H1 I T A 0.526 0.558 0.190 0.562 0.565 1.000 0.497 0.554 0.087
H2 D C G 0.229 0.192 0.058 0.190 0.185 0.913 0.260 0.197 0.020*
H3 I C A 0.136 0.140 0.856 0.140 0.135 0.924 0.134 0.143 0.718
H4 D C A 0.050 0.053 0.825 0.044 0.055 0.595 0.054 0.052 0.899
* P < 0.05BMC Medical Genetics 2009, 10:130 http://www.biomedcentral.com/1471-2350/10/130
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revealed that our study had a power of 0.95 (for the D-car-
rying genotype of 296921-296923delTTG) and 0.79 (for
the G-carrying genotype of rs2288775) to detect the dif-
ference across cases and controls in this study (α = 0.05).
Furthermore, the distribution of all polymorphisms is
under Hardy-Weinberg equilibrium (data not shown),
which suggests the results of this study are unlikely to be
biased by population stratification or admixture for essen-
tial hypertension. Together, it is strongly suggested that
rs2288745 and 296921-296923delTTG may be associated
with essential hypertension.
The mechanisms by which the common SNPs (296921-
296923delTTG and rs2288775) might contribute to
hypertension are unknown. The two common SNPs are
located in intronic regions. It is generally assumed that the
sequence of any given intron is junk DNA with no biolog-
ical function. More recently, however, this is being dis-
puted. Introns contain several short sequences that are
important for efficient splicing, such as acceptor and
donor sites at either end of the intron, as well as a branch
point site, which are required for proper splicing by the
spliceosome. Further studies are critically needed to deter-
mine whether the polymorphisms of 296921-
296923delTTG and rs2288775 affect the splicing of
mRNA of NEDD4L. In addition, these two SNPs may be
mere genetic markers and it may be in linkage disequilib-
rium with another functional variation within the
NEDD4L and other functional polymorphisms may play
more important roles in hypertension. Rs4149601
(16229 bps from exon 2) of NEDD4L is associated with
hypertension in African Americans and Caucasians and
rs3865418 (4106 bps from exon 13) has been shown to
have a "flip-flop" association with hypertension in two
Caucasian samples [10]. The region harboring these two
SNPs was not included by our sequencing method, thus a
greater density of genotyping around NEDD4L or the two
common SNP sites is needed.
In the HapMap database, we found genotype data for
rs2288774, but not for rs2288775. The frequencies of
minor alleles of rs2288774 are different between various
ethnicities (Japanese, Chinese Han, Caucasians, blacks,
and Xinjiang Kazakh [from the data of the present study];
31.0%, 32.0%, 48.0%, 33.0%, and 41.2%, respectively).
This strongly indicates that the distributions of genotypes
of common SNPs might be different between ethnicities.
As association studies are not consistently reproducible as
a result of false positives, false negatives, and problems
with true variability in association between different pop-
ulations [22], the associations of 296921-296923delTTG
and rs2288775 with essential hypertension must be re-
examined in another population.
The present population-based case-control study also
showed gender-specific (for females only) significant dif-
ferences in genetic markers between essential hyperten-
sion patients and control individuals. Moreover, there was
a significant gene-by-gender interaction on BP traits in
this study. Several studies have reported gender-specific
effects of gene variants and gene-by-gender interactions in
human hypertension [23-26]. These data support our
findings. Regarding the mechanisms by which two com-
mon SNPs (296921-296923delTTG and rs2288775)
might contribute to essential hypertension in only
females, it has been reported that NEDD4L expression is
down-regulated in prostate cancer and up-regulated fol-
lowing androgen treatment [27,28], suggesting that the
variations of NEDD4L  are associated with androgen-
mediated gender differences in essential hypertension.
Unfortunately, we could not obtain data on plasma sex
hormones as we were not able to obtain informed consent
to collect blood samples for the purpose of such measure-
ments. It appears that two common SNPs (296921-
296923delTTG and rs2288775) in the NEDD4L and/or
neighboring genes are associated with essential hyperten-
sion in females. Furthermore, there is a significant differ-
Table 6: Comparing of urinary Na excretion rate and plasma Na between different genotypes by Covariate variance analysis adjusting 
for age, smoking, and drinking.
296921-296923delTTG Rs2288775
I/I+I/D D/D P A/A A/G+G/G P
UNa rate (uM/min)
Total 169.27 ± 87.71 143.92 ± 69.00 0.027* 167.69 ± 86.10 166.86 ± 87.43 0.954
Male 186.75 ± 92.03 180.50 ± 83.87 0.798 182.82 ± 91.23 193.80 ± 91.83 0.278
Female 155.50 ± 81.69 126.49 ± 53.47 0.032* 156.21 ± 80.32 147.25 ± 78.73 0.233
Pl Na (mmol/L)
Total 144.69 ± 8.83 144.11 ± 9.62 0.496 144.67 ± 8.46 144.58 ± 9.49 0.900
Male 145.67 ± 8.61 143.65 ± 6.02 0.238 145.22 ± 7.08 145.98 ± 10.27 0.330
Female 143.94 ± 8.93 144.34 ± 11.09 0.846 144.25 ± 9.36 143.63 ± 8.83 0.471
Una rate; urinary Na excretion rate, PlNa; plasma Na. * P < 0.05BMC Medical Genetics 2009, 10:130 http://www.biomedcentral.com/1471-2350/10/130
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ence between males and females for self-reported
smoking status in this study population (> 50% of males
and only about 1% of females report being smokers). Is it
apparent that the gene-by-gender interaction is only a
proxy for an underlying gene-by-smoking interaction?
Therefore, we next assessed the gene-by-smoking interac-
tion effects on BP traits, but no significant interaction was
found in this study. Together, it is suggested that the gen-
der-specific findings in this study are reliable.
Conclusion
In summary, two common SNPs of NEDD4L (296921-
296923delTTG and rs2288775), were found to be associ-
ated with essential hypertension in Kazakh females. This
reconfirms that genetic variations of NEDD4L might be
involved in the pathogenesis of essential hypertension.
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